The DOI matches its Crossref record.
VON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
Abstract
A population-based study in south-east Wales (population 668,100) identified 135 patients with von Recklinghausen neurofibromatosis (prevalence 20/10(5]. In addition to multiple café-au-lait spots and/or dermal neurofibromas, freckling was present in the axilla (67%), groin (44%) or submammary areas (29% of adult females). Although not a criterion for diagnosis, Lisch nodules were almost invariably present in the iris (93% of patients overall; 96% of those aged greater than or equal to 20 yrs). The complications of von Recklinghausen neurofibromatosis in this cohort (n = 135 unless stated) were plexiform neurofibromas (40/125), severe mental retardation (1), epilepsy (6), optic glioma (2), spinal neurofibroma (2), aqueduct stenosis (2), meningioangiomatosis (1), scoliosis requiring surgery (6), pseudoarthrosis (3), delayed puberty (2), visceral and endocrine tumours (6), and congenital glaucoma (1). There were no cases of acoustic neuroma. Considering all living family members aged greater than or equal to 18 yrs, together with their deceased relatives, the frequency of CNS and malignant tumours related to the disease was 4.4-5.2%. Uncomplicated von Recklinghausen neurofibromatosis is disfiguring but not a major cause of morbidity. The management of the disease relates to its complications which can be divided into three categories: those which occur in childhood and cause lifelong morbidity (moderate-severe mental handicap, facial plexiform neurofibromas, orthopaedic), those which can occur at any time but are 'treatable' (benign disorders of the nervous system, visceral and endocrine tumours, renal artery stenosis), and malignant or CNS tumours. The combined frequency for each category based on this survey was 12%, 16% and 4.4-5.2%, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,053
Self-citationNeurofibromatosis Type 1 Revisited
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009) · Pediatrics · doi:10.1542/peds.2007-3204 · Cited by 695
Neurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Epidemiology of neurofibromatosis type 1
Friedman, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<1::aid-ajmg3>3.0.co;2-8 · Cited by 577
Listernick, R., Charrow, J., Greenwald, M., & Mets, M. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70122-9 · Cited by 548
Huson, S. M., Compston, D. A., Clark, P., & Harper, P. S. (1989) · Journal of Medical Genetics · doi:10.1136/jmg.26.11.704 · Cited by 540
Self-citationNeurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
Ferner, R. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70075-3 · Cited by 511
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Ratner, N., & Miller, S. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3911 · Cited by 493
Boyd, K. P., Korf, B. R., & Theos, A. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.051 · Cited by 486
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 478
Evans, D. G., Huson, S. M., Donnai, D., Neary, W., Blair, V, Teare, D., Newton, V, Strachan, T., Ramsden, R., & Harris, R. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.12.841 · Cited by 468
Self-citationParry, D. M., Eldridge, R., Kaiser‐Kupfer, M. I., Bouzas, E. A., Pikus, A., & Patronas, N. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320520411 · Cited by 421
Zöller, M. E. T., Rembeck, B., Odén, A., Samuelsson, M., & Angervall, L. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970601)79:11<2125::aid-cncr9>3.3.co;2-b · Cited by 395
Korf, B. R. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w · Cited by 390
The clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri, M., & Huson, S. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1433 · Cited by 387
Self-citationMolecular genetics of neurofibromatosis type 1 (NF1).
Shen, M. H., Harper, P. S., & Upadhyaya, M. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.1.2 · Cited by 377
Self-citationUpadhyaya, M., Huson, S. M., Davies, M., Thomas, N., Chuzhanova, N., Giovannini, S., Evans, D. G., Howard, E., Kerr, B., Griffiths, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510781 · Cited by 362
Self-citationMalignancy in Neurofibromatosis Type 1
Korf, B. R. (2000) · The Oncologist · doi:10.1634/theoncologist.5-6-477 · Cited by 328
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
Scott, R. H., Stiller, C. A., Walker, L., & Rahman, N. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041723 · Cited by 322
Association between benign and malignant peripheral nerve sheath tumors in NF1
Tucker, T., Wolkenstein, P., Revuz, J., Zeller, J., & Friedman, J. M. (2005) · Neurology · doi:10.1212/01.wnl.0000168830.79997.13 · Cited by 311
Guillamo, J.-S., Creange, A., Kalifa, C., Grill, J., Rodriguez, D., Doz, F., Barbarot, S., Zerah, M., Sanson, M., Bastuji-Garin, S., et al. (2003) · Brain · doi:10.1093/brain/awg016 · Cited by 295
Ferner, R. E., Golding, J. F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V., & O’Doherty, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm450 · Cited by 286
A neurofibromatosis-1-regulated pathway is required for learning in Drosophila
Guo, H.-F., Tong, J., Hannan, F., Luo, L., & Zhong, Y. (2000) · Nature · doi:10.1038/35002593 · Cited by 257
Rescue of a Drosophila NF1 Mutant Phenotype by Protein Kinase A
The, I., Hannigan, G. E., Cowley, G. S., Reginald, S., Zhong, Y., Gusella, J. F., Hariharan, I. K., & Bernards, A. (1997) · Science · doi:10.1126/science.276.5313.791 · Cited by 255
Gingival Overgrowth in Children: Epidemiology, Pathogenesis, and Complications. A Literature Review
Doufexi, A., Mina, M., & Ioannidou, E. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.1.3 · Cited by 146
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
Tucker, T., Friedman, J. M., Friedrich, R. E., Wenzel, R., Fünsterer, C., & Mautner, V.-F. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061051 · Cited by 122
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
Ferner, R. E., Hughes, R. A. C., Hall, S. M., Upadhyaya, M., & Johnson, M. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.021683 · Cited by 82
Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis
Franz, D. N., & Weiss, B. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0269-4 · Cited by 58
Metadata
- Authors
- HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1988
- Volume
- 111
- Issue
- 6
- Pages
- 1355-1381
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2131532433
- Cited by
- 686
- References
- 0
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.